CD36 and metabolic dysfunction-associated steatotic liver disease: Higher FAT/CD36 and FABP levels were observed in liver of nonalcoholic fatty liver disease (NAFLD) patients who are often accompanied with high levels of inflammatory factors, which were positively related to liver fat content [23, 24].